CIDRAP newsletters options
The 2 cases add to what is the worst year for measles in the US since the disease was declared eliminated in 2000.
An analysis of national action plans finds a 'marked divide' in how high-income and low-income countries are able to respond to AMR.
The results of a randomized controlled trial show a single dose of benzathine penicillin G is noninferior to 3 doses for treating early syphilis.
In other developments, new FDA policies are questioning flu and COVID vaccine coadministration, shown to be safe and convenient for patients.
Azelastine used as a preventive measure reduced COVID-19 infections 69%.
It is unclear at this time if the alliance will distribute COVID-19 vaccines.
In other developments, the CDC reschedules a clinician's update on measles as 2 states announce a few new cases.
Spray recipients who were younger than 65 years, women, and vaccinated were at the lowest risk for infection.
Maryland-based Zeteo Tech will receive $1 million to advance work on a novel test that can diagnose LRTIs from exhaled breath.
Also, as fallout continues regarding narrowed FDA approval for COVID vaccines, New Mexico issues a health order to sort out pharmacy access.
During the 2022-23 and 2024-25 flu seasons, the incidence of cardiorespiratory hospitalization was 2.25% in the high-dose group and 2.38% in the standard-dose group.
CIDRAP Director Michael Osterholm and co-author Mark Olshaker's new book examines the lessons learned from the COVID-19 pandemic and how a pandemic caused by an even deadlier virus might play out.
The findings underscore the importance of starting metformin soon after diagnosis, the authors say.
Two people have been hospitalized in Wisconsin's outbreak centered in Oconto County.
Ensitrelvir, also known as Xocova, is already approved for use in Japan.
The outbreak marks the first at a US commercial farm in nearly 2 months.
The case involves an unvaccinated 4-year-old boy who developed acute flaccid paralysis caused by circulating vaccine-derived poliovirus type 2.
Five African countries are experiencing acute cholera outbreaks with high death rates.
Impacts from chaos at the CDC and more limited FDA COVID vaccine clearances are stirring concern and confusion.
Over the past week, test positivity for SARS-CoV-2 rose from 10.2% to 11.2%.
